MITOQ
Live / Registered — Registered and renewed (as of 12 Jul 2024)
What this means for you
Registered since 29 Jun 2004. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 29 Jun 2024).
Record
- Serial number
- 76484733
- Registration number
- 2857424
- Mark type
- Stylized text
- Filed
- 24 Jan 2003
- Published for opposition
- 06 Apr 2004
- Registered
- 29 Jun 2004
- Next maintenance due
- 29 Jun 2024
- Attorney of record
- Syed Abedi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, antioxidants targeting mitochondria; dietary supplements
Owner
- ANTIPODEAN PHARMACEUTICALS, INC., Auckland, DE, US
- Antipodean Biotechnology Limited, San Francisco, CA, NZ
- Antipodean Biotechnology Limited, Auckland, NZ
- Antipodean Biotechnology Limited, Auckland, NZ
Prosecution history
- 12 Jul 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 12 Jul 2024 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 12 Jul 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 12 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Apr 2024 — TEAS SECTION 8 & 9 RECEIVED
- 29 Jun 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 09 Apr 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 09 Apr 2014 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 09 Apr 2014 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 29 Jan 2014 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 26 Feb 2014 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 13 Feb 2014 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 13 Feb 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Jan 2014 — TEAS SECTION 8 & 9 RECEIVED
- 24 Apr 2012 — NOTICE OF SUIT